Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088047 · ClinicalTrials.gov registry record · NA
The Effects of ProFoveate on Reducing Self-Stimulating Behaviors
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02088047: Clinical Trial NA study, sponsored by University of Arkansas.
NCT02088047 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02088047, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is designed to pilot an intervention technique to reduce the self-stimulating behaviors seen in individuals with autism spectrum disorders using intervention with ProFoveate pellets. Self-stimulating behaviors like hand flapping, eye blinking, and rocking, can interfere with the individual's ability to interact with their peers. Participants will wear the pellets for four week and measures with taken again. Another group of participants will not get the pellets. Both groups will be tested at the beginning and end of the study. Any variations in self-stimulating behaviors will be documented through parent report, Observational data. The investigators hypothesize that they will see changes in self- stimulating behaviors as a result of the strategic placement of the ProFoveate™ pellets on the ears of one group of the participants.
Primary Outcome
Only 4 participants completed enrollment.Only 3 participants completed study. Study was terminated due to low enrollment.
Interventions
- DEVICE ProFoveate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-08-30 |
| Est. Completion | 2018-10-04 |
| Phase | NA |
Why NCT02088047 stopped before completion
NCT02088047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which ProFoveate is the first listed.
NCT02088047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02088047 about?
NCT02088047 is a clinical study titled "The Effects of ProFoveate on Reducing Self-Stimulating Behaviors". This study is designed to pilot an intervention technique to reduce the self-stimulating behaviors seen in individuals with autism spectrum disorders using intervention with ProFoveate pellets. Self-stimulating behaviors like hand flapping, eye blinking, and rocking, can interfere with the individua...
What is the current status of trial NCT02088047?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-08-30. Estimated completion is 2018-10-04.
What interventions are being tested in trial NCT02088047?
The interventions under investigation include: ProFoveate (DEVICE).
Who is sponsoring clinical trial NCT02088047?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02088047's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI